查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1377813

微流控免疫分析市场：按产品、技术、应用、最终用户划分 - 2030 年全球预测

Microfluidic Immunoassay Market by Product (Cartridge, Reagents, System), Technology (Electrochemical, Optical), Application (Cardiology, Oncology, Infectious Disease), and End User (Pharmaceutical, Hospital) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 269 Pages | 订单完成后即时交付

价格

微流控免疫分析市场：依产品（卡盒[聚合物、玻璃、硅胶]、试剂、系统）、依技术（电化学、光学）、依应用（心臟病学、肿瘤学、传染病）、按最终用户（製药、医院） - 世界预测到2030年

全球微流控免疫分析市场预计2030年将达到14.7亿美元，2023年至2030年复合年增长率为7.4%。

经过广泛的二次和初步研究以及对市场情景的详细分析，本报告对关键行业驱动因素、限制因素、挑战和机会进行了分析。该市场的成长是由于微流控免疫分析在药物发现和开发以及生物标誌物检测中的使用不断增加、晶片实验室免疫分析相对于传统免疫分析的优越性以及製药和生物技术公司对研发的越来越多的使用推动的. 更加关註生物和化学测定的小型化。然而，微流体装置中的气泡形成和死体积限制了该市场的成长。

此外，对现场诊断的需求不断增长以及微流控免疫分析技术的最新进展预计将创造市场成长机会。然而，新兴国家微流控晶片设计中合适的基板材料和产品设计的选择以及成本相关的限制给市场利益相关者带来了重大挑战。

该报告基于对产品组合、区域影响力以及行业领先市场参与者多年来（2020-2023）采用的关键策略发展的广泛评估，提供了竞争格局。全球微流控免疫分析市场的主要公司有Becton, Dickinson and Company（美国）、Revvity, Inc.（美国）、Abbott Laboratories（美国）、Siemens Healthineers AG（德国）、Nanomix Corporation（美国）、Micropoint Biotechnologies Co.（中国）、Biosurfit SA（葡萄牙）、Koninklijke Philips NV（荷兰）、NanoEnTek Inc.（韩国）和 QuidelOrtho Corporation（美国）。

在本报告研究的所有产品中，耗材领域预计将在 2023 年占据微流控免疫分析市场的最大份额。此细分市场的巨大市场份额归因于试剂盒的重复使用、用于疾病早期诊断的特定疾病试剂盒组合的增加以及产品批准的增加。试剂和试剂盒的不断进步、用户友好的诊断试剂盒的开发以及临床和研究实验室中微流控免疫分析盒的采用正在对微流控耗材的需求产生积极影响。

在本报告调查的技术中，电化学检测领域预计在预测期内复合年增长率最高。电化学检测因其成本低、省电、样品和试剂消耗低、便携性以及响应时间短等优点而越来越多地应用于微流控免疫分析，推动了该领域最高的复合年增长率，这也是其昂贵的因素。

在本报告研究的所有应用中，预计心血管领域将在2023年占据微流控免疫分析市场的最大份额。该领域的巨大市场份额归因于微流控盒在心血管疾病生物标记分析和疾病机制阐明中的应用不断增加。心臟生物标记研究的生物医学和临床领域对微流控免疫分析的需求不断增加，占据了最大的市场份额。

在本报告研究的所有最终用户中，製药和生技公司领域预计在预测期内将以最高的复合年增长率成长。此细分市场复合年增长率最高的原因是製药和生物技术公司增加研发投资、微流控免疫分析在药物发现研发中的广泛使用以及对个人化医疗研究的日益重视等因素。製药公司不断增加的研发支出也贡献了该细分市场的最大份额。

对全球微流控免疫分析市场区域状况的详细分析为五个关键地区（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）以及每个地区的主要国家提供了深入的定性和定量见解。地区。提供覆盖范围。2023年，北美预计将占据微流控免疫分析市场的最大份额，其次是欧洲、亚太地区、拉丁美洲以及中东和非洲。北美的高份额是由于製药和生物技术公司识别药物和生物标誌物的研发成本较高、慢性病患病率上升以及医疗保健支出不断增加。这是由于该地区存在强大的市场参与者以及政府的有利措施研究与开发。根据国会预算办公室预测，美国药物研发支出将从2020年的911亿美元增加到2021年的1,023亿美元。

研究范围：

微流控免疫分析市场评估（分产品）

  • 消耗品
  • 墨盒
    • 聚合物
    • 玻璃
    • 硅
  • 试剂
  • 系统

微流控免疫分析市场评估（按技术）

  • 电化学检测
  • 光学检测

微流控免疫分析市场评估：依应用分类

  • 心臟病学
  • 单一生物标记检测
  • 多重生物标记检测
  • 感染
  • 肿瘤学
  • 其他应用

注意：其他应用包括怀孕、糖尿病、甲状腺、肾臟疾病和药物滥用测试。

微流控免疫分析市场评估（按最终用户）

  • 製药和生物技术公司
  • 诊断实验室
  • 医院
  • 其他最终用户

註：其他最终使用者包括家庭医疗保健、自我检测、学术机构/研究中心、法医实验室等。

微流控免疫分析市场评估（按地区）

  • 北美
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲 (RoE)
  • 亚太地区 (APAC)
  • 中国
  • 日本
  • 印度
  • 其他亚太地区 (RoAPAC)
  • 拉丁美洲
  • 中东/非洲

目录

第 1 章 简介

第二章研究方法论

第三章执行摘要

第四章市场洞察

  • 市场
  • 概述
  • 影响市场成长的因素
    • 市场动态影响分析
      • 在药物发现/市场开发和生物标记检测中越来越多地使用微流控免疫分析来推动市场成长
      • 气泡的形成和死体积限制了微流体装置的采用
      • 对现场检测的需求不断增长为市场参与者创造了成长机会
      • 为微流控晶片设计选择合适的基板材料仍然是市场参与者面临的关键挑战
    • 因子分析
  • 技术趋势
    • 多重面板侦测
    • 纸基微流体
  • 监管分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
    • 拉丁美洲
    • 中东
      • 沙特阿拉伯
  • 价格分析
  • 波特五力分析

第五章微流控免疫分析市场产品评估

  • 概述
  • 消耗品
    • 墨盒
      • 聚合物
      • 玻璃
      • 硅
    • 试剂
  • 系统

第六章 微流体免疫分析技术市场评价

  • 概述
  • 电化学检测
  • 光学检测

第七章微流控免疫分析市场的应用评估

  • 概述
  • 心臟病学
    • 单一生物标记检测
    • 多重生物标记检测
  • 感染
  • 肿瘤学
  • 其他应用

第八章最终用户的微流控免疫分析市场评估

  • 概述
  • 製药和生物技术公司
  • 诊断实验室
  • 医院
  • 其他最终用户

第九章微流控免疫分析市场的区域评估

  • 概述
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 拉丁美洲
  • 中东/非洲

第 10 章 竞争分析

  • 概述
  • 主要成长策略
  • 竞争标桿
  • 比赛仪表板
    • 产业领导者
    • 差异化因素
    • 先锋队
    • 启动

第十一章 公司简介（公司概况、财务概况、产品组合、策略发展）

  • Abbott Laboratories
  • Revvity, Inc.（Formerly PerkinElmer, Inc.）
  • Siemens Healthineers AG.
  • QuidelOrtho Corporation.
  • Nanomix, Inc.
  • Becton, Dickinson and Company
  • Micropoint Biotechnologies Co., Ltd.
  • Biosurfit SA
  • Koninklijke Philips N.V.
  • NanoEnTek Inc.

（註：我们提供了前 5 名公司的 SWOT 分析。）

第十二章附录

Product Code: MRHC - 104334

Microfluidic Immunoassay Market by Product (Cartridge [Polymer, Glass, Silicon], Reagents, System), Technology (Electrochemical, Optical), Application (Cardiology, Oncology, Infectious Disease), and End User (Pharmaceutical, Hospital)-Global Forecast to 2030

The global microfluidic immunoassay market is expected to reach $1.47 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increasing use of microfluidic immunoassays in drug discovery & development and biomarker detection, the advantages of lab-on-chip immunoassays over conventional immunoassays, pharmaceutical & biotechnology companies' increasing focus on research & development, and the miniaturization of biological and chemical assays. However, bubble formation and dead volume in microfluidics devices restrain the growth of this market.

Moreover, the increasing demand for point-of-care diagnostics and recent advancements in microfluidic immunoassay technology are expected to generate market growth opportunities. However, the selection of suitable substrate materials for designing microfluidic chips and product design and cost-related limitations in developing countries are major challenges for market stakeholders.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2023). The key players operating in the global microfluidic immunoassay market are Becton, Dickinson and Company (U.S.), Revvity, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Nanomix Corporation (U.S.), Micropoint Biotechnologies Co., Ltd. (China), Biosurfit SA (Portugal), Koninklijke Philips N.V. (Netherland), NanoEnTek Inc. (South Korea), and QuidelOrtho Corporation (U.S.).

Among all the products studied in this report, in 2023, the consumables segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to the repetitive use of kits, the growing portfolio of disease-specific kits for early diagnosis of diseases, and the increasing product approvals. The continuous advancements in reagents and kits, the development of user-friendly diagnostic kits, and the adoption of microfluidic immunoassay cartridges in clinical and research laboratories are positively impacting the demand for consumables used in microfluidics.

Among all the technologies studied in this report, the electrochemical detection segment is projected to register the highest CAGR during the forecast period. Electrochemical detection is increasingly used in the microfluidic immunoassay owing to benefits such as low cost & power requirements, low sample & reagent consumption, portability, and short response time, contributing to the highest CAGR of this segment.

Among all the applications studied in this report, in 2023, the cardiology segment is expected to account for the largest share of the microfluidic immunoassay market. The large market share of this segment is attributed to increasing applications of microfluidic cartridges in biomarker profiling of cardiovascular diseases and understanding disease mechanisms. The demand for microfluidic immunoassay is increasing in biomedical and clinical fields for research on cardiac biomarkers, contributing to the largest share of the market.

Among all the end users studied in this report, the pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to factors such as the increasing R&D investments by pharmaceutical & biotechnology companies, the widespread utilization of microfluidic immunoassay in drug discovery & development, and a growing emphasis on personalized medicine research. The rising spending on R&D by pharmaceutical companies is also contributing to the largest share of this segment.

An in-depth analysis of the geographical scenario of the global microfluidic immunoassay market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the microfluidic immunoassay market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is attributed to the region's high R&D spending by the pharmaceutical & biotechnology companies for the development of drugs and biomarker identification, increasing prevalence of chronic diseases, rising healthcare expenditure, presence of leading market players in the region, and favorable government initiatives for research & development. According to the U.S. Congressional Budget Office, U.S. pharmaceutical R&D expenditure increased from USD 91.1 billion in 2020 to USD 102.3 billion in 2021.

Scope of the Report:

Microfluidic Immunoassay Market Assessment, by Product

  • Consumables
  • Cartridges
    • Polymer
    • Glass
    • Silicon
  • Reagents
  • Systems

Microfluidic Immunoassay Market Assessment, by Technology

  • Electrochemical Detection
  • Optical Detection

Microfluidic Immunoassay Market Assessment, by Application

  • Cardiology
  • Single Biomarker Detection
  • Multiplexed Biomarker Detection
  • Infectious Diseases
  • Oncology
  • Other Applications

Note: Other applications consist of pregnancy, diabetes, thyroid, kidney diseases, and drug of abuse testing

Microfluidic Immunoassay Market Assessment, by End User

  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospital
  • Other End Users

Note: Other end users include home healthcare, self-testing, academic institutes & research centers, and forensic labs.

Microfluidic Immunoassay Market Assessment, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
      • 4.2.1.1. Increasing Use of Microfluidic Immunoassays in Drug Discovery & Development and Biomarker Detection Driving Market Growth
      • 4.2.1.2. Bubble Formation and Dead Volume Limiting the Adoption of Microfluidics Devices
      • 4.2.1.3. Increasing Demand for Point-of-Care Testing Generating Growth Opportunities for Market Players
      • 4.2.1.4. Selecting Suitable Substrate Materials to Design Microfluidic Chips to Remain a Major Challenge for Market Players
    • 4.2.2. Factor Analysis
  • 4.3. Technology Trends
    • 4.3.1. Multiplexed Panel Detection
    • 4.3.2. Paper-Based Microfluidics
  • 4.4. Regulatory Analysis
    • 4.4.1. North America
      • 4.4.1.1. U.S.
      • 4.4.1.2. Canada
    • 4.4.2. Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
    • 4.4.4. Latin America
    • 4.4.5. Middle East
      • 4.4.5.1. Saudi Arabia
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of Substitutes
    • 4.6.4. Threat of New Entrants
    • 4.6.5. Degree of Competition

5. Microfluidic Immunoassay Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Cartridges
      • 5.2.1.1. Polymer
      • 5.2.1.2. Glass
      • 5.2.1.3. Silicon
    • 5.2.2. Reagents
  • 5.3. Systems

6. Microfluidic Immunoassay Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Electrochemical Detection
  • 6.3. Optical Detection

7. Microfluidic Immunoassay Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Cardiology
    • 7.2.1. Single Biomarker Detection
    • 7.2.2. Multiplexed Biomarker Detection
  • 7.3. Infectious Diseases
  • 7.4. Oncology
  • 7.5. Other Applications

8. Microfluidic Immunoassay Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospital
  • 8.5. Other End Users

9. Microfluidic Immunoassay Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies

11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

  • 11.1. Abbott Laboratories
  • 11.2. Revvity, Inc. (Formerly PerkinElmer, Inc.)
  • 11.3. Siemens Healthineers AG.
  • 11.4. QuidelOrtho Corporation.
  • 11.5. Nanomix, Inc.
  • 11.6. Becton, Dickinson and Company
  • 11.7. Micropoint Biotechnologies Co., Ltd.
  • 11.8. Biosurfit SA
  • 11.9. Koninklijke Philips N.V.
  • 11.10. NanoEnTek Inc.

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

List of Tables

  • Table 1 Funding for Microfluidic Immunoassay Research & Development
  • Table 2 Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
  • Table 3 Research Studies on Paper-Based Microfluidics, 2017-2023
  • Table 4 Authorities Regulating In Vitro Diagnostic Products, by Country/Region
  • Table 5 Medical Devices Regulatory Authorities in the Rest of APAC Countries
  • Table 6 Average Selling Prices of Microfluidic Immunoassay Products (USD/Unit)
  • Table 7 Quidelortho Corporation (U.S.): Product Pricing (USD/Unit)
  • Table 8 Abbott Laboratories (U.S.): Product Pricing (USD/Unit)
  • Table 9 Global Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 10 Global Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 11 Global Microfluidic Immunoassay Consumables Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 13 Global Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Polymer-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Glass-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Silicon-Based Microfluidic Immunoassay Cartridges Market, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Microfluidic Immunoassay Reagents Market, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Microfluidic Immunoassay Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 20 Global Microfluidic Immunoassay Market for Electrochemical Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Optical Detection Techniques for Microfluidic Applications
  • Table 22 Global Microfluidic Immunoassay Market for Optical Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 24 Clinically Significant Cardiac Biomarkers
  • Table 25 Global Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
  • Table 26 Global Microfluidic Immunoassay Market for Cardiology, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Commercially Available Tests for Single Cardiac Biomarker Detection
  • Table 28 Global Microfluidic Immunoassay Market for Single Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Commercially Available Tests for Multiplexed Cardiac Biomarker Detection
  • Table 30 Global Microfluidic Immunoassay Market for Multiplexed Biomarker Detection, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global Microfluidic Immunoassay Market for Infectious Disease, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Clinically Significant Oncology Biomarkers
  • Table 33 Global Microfluidic Immunoassay Market for Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Commercially Available Tests for Diabetes Biomarker Detection
  • Table 35 Global Microfluidic Immunoassay Market for Other Applications, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 37 Global Microfluidic Immunoassay Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 38 Global Microfluidic Immunoassay Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 39 Global Microfluidic Immunoassay Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 40 Global Microfluidic Immunoassay Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 41 Global Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
  • Table 42 North America: Microfluidic Immunoassay Market, by Country, 2021-2030 (USD Million)
  • Table 43 North America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 44 North America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 45 North America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 46 North America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 47 North America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 48 North America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 49 North America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 50 U.S.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 51 U.S.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 52 U.S.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 53 U.S.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 54 U.S.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 55 U.S.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 56 U.S.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 57 Canada: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 58 Canada: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 59 Canada: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 60 Canada: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 61 Canada: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 62 Canada: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 63 Canada: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 64 Europe: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million
  • Table 65 Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 66 Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 67 Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 68 Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 69 Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 70 Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 71 Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 72 Germany: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 73 Germany: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 74 Germany: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 75 Germany: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million
  • Table 76 Germany: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
  • Table 77 Germany: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 78 Germany: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 79 France: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 80 France: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 81 France: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 82 France: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 83 France: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 84 France: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 85 France: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 86 U.K.: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 87 U.K.: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 88 U.K.: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 89 U.K.: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 90 U.K.: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 91 U.K.: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 92 U.K.: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 93 Italy: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 94 Italy: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 95 Italy: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 96 Italy: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 97 Italy: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 98 Italy: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 99 Spain: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 100 Spain: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 101 Spain: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 102 Spain: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 103 Spain: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 104 Spain: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 105 Spain: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 106 Covid-19 Cases in European Countries
  • Table 107 Rest of Europe: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 108 Rest of Europe: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 109 Rest of Europe: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 110 Rest of Europe: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 111 Rest of Europe: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 112 Rest of Europe: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 113 Rest of Europe: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 114 Asia-Pacific: Microfluidic Immunoassay Market, by Country/Region, 2021-2030 (USD Million)
  • Table 115 Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 116 Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 117 Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material,2021-2030 (USD Million)
  • Table 118 Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 119 Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030(USD Million)
  • Table 120 Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 121 Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 122 China: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 123 China: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 124 China: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 125 China: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 126 China: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 127 China: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 128 China: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 129 Japan: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 130 Japan: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 131 Japan: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 132 Japan: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 133 Japan: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 134 Japan: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 135 Japan: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 136 India: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 137 India: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 138 India: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 139 India: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 140 India: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 141 India: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 142 India: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 143 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 144 Rest of Asia-Pacific: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 145 Rest of Asia-Pacific: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 146 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 147 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 148 Rest of Asia-Pacific: Microfluidic Immunoassay Market for Cardiology, by Type, 2021 2030 (USD Million)
  • Table 149 Rest of Asia-Pacific: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 150 Latin America: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 151 Latin America: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 152 Latin America: Microfluidic Immunoassay Cartridges Market, by Material, 2021-2030 (USD Million)
  • Table 153 Latin America: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 154 Latin America: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 155 Latin America: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 156 Latin America: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 157 Saudi Arabia, South Africa, and UAE Estimated Cancer Incidence
  • Table 158 Middle East & Africa: Microfluidic Immunoassay Market, by Product, 2021-2030 (USD Million)
  • Table 159 Middle East & Africa: Microfluidic Immunoassay Consumables Market, by Type, 2021-2030 (USD Million)
  • Table 160 Middle East & Africa: Microfluidic Immunoassay Cartridges Market, by Material, 2021 2030 (USD Million)
  • Table 161 Middle East & Africa: Microfluidic Immunoassay Market, by Technology, 2021-2030 (USD Million)
  • Table 162 Middle East & Africa: Microfluidic Immunoassay Market, by Application, 2021-2030 (USD Million)
  • Table 163 Middle East & Africa: Microfluidic Immunoassay Market for Cardiology, by Type, 2021-2030 (USD Million)
  • Table 164 Middle East & Africa: Microfluidic Immunoassay Market, by End User, 2021-2030 (USD Million)
  • Table 165 Recent Developments, by Company, 2020-2023